@article{2b13c1860d9744c6b44959dbe02171a3,
title = "Immunomodulating Nanomedicine for Cancer Therapy",
abstract = "Nanomaterials offer unique advantages as drug-delivery vehicles for cancer therapeutics. For immuno-oncology applications, cancer nanomedicine should be developed beyond drug-delivery platforms. A greater emphasis on actively modulating host anticancer immunity using nanomaterials provides new avenues for developing novel cancer therapeutics.",
keywords = "Nanomedicine, cancer immunotherapy, cancer vaccine, drug delivery, nanotechnology",
author = "Zhigang Liu and Wen Jiang and Jutaek Nam and Moon, {James J.} and Kim, {Betty Y.S.}",
note = "Funding Information: This work was supported by the Mayo Clinic Center for Regenerative Medicine (B.Y.S.K.), the National Institute of Neurological Disorders and Stroke Grant R01 NS104315 (B.Y.S.K.), the Florida Center for Brain Tumor Research & Accelerate Brain Cancer Cure (B.Y.S.K.), Cancer Prevention and Research Institute of Texas CPRIT (RR180017; W.J.), the National Natural Science Foundation of China (grant no. 81572500), and the Hunan Young Talent (grant no. 2016RS3036). The authors thank C. Wogan of MD Anderson Cancer Center{\textquoteright}s Division of Radiation Oncology for editorial assistance. Publisher Copyright: {\textcopyright} 2018 American Chemical Society.",
year = "2018",
month = nov,
day = "14",
doi = "10.1021/acs.nanolett.8b02340",
language = "English (US)",
volume = "18",
pages = "6655--6659",
journal = "Nano Letters",
issn = "1530-6984",
publisher = "American Chemical Society",
number = "11",
}